Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
VIR	VIR BIOTECHNOLOGY INC	$839.32M	-38.90%	-32.80%	-40.89%	-40.80%	0.22	8.71	98.90%	-703.40%	-704.95%
THRD	THIRD HARMONIC BIO INC	$231.83M	-16.50%	-16.00%	-15.82%	-764.60%	0.03	40.87	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$80.74M	-156.80%	-95.50%	-30.67%	6,189.80%	0.22	15.00	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$88.86M	-60.00%	-56.90%	-73.83%	-65.80%	0.12	9.35	N/A	N/A	N/A
GERN	GERON CORP	$904.40M	-57.00%	-35.40%	-30.88%	-40.20%	1.12	5.56	98.40%	-226.70%	-202.70%
FBRX	FORTE BIOSCIENCES INC	$44.14M	-132.00%	-103.10%	-67.60%	-1,017.80%	0.17	6.76	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$892.37M	-29.20%	-27.40%	-28.66%	-47.40%	0.05	19.99	N/A	N/A	N/A
SEPN	SEPTERNA INC	$287.10M	-37.60%	-24.40%	-16.29%	-52.20%	0.09	27.77	100.00%	-6,678.90%	-6,725.21%
NVCT	NUVECTIS PHARMA INC	$245.38M	-160.80%	-102.80%	-195.61%	292.00%	0.92	2.09	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$353.95M	-43.80%	-26.20%	-29.06%	-42.60%	0.83	10.88	-12.50%	-2,180.50%	-2,073.52%
ATNM	ACTINIUM PHARMACEUTICALS INC	$40.87M	-96.40%	-45.40%	-55.63%	1,389.10%	1.35	9.14	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$418.83M	-362.00%	-71.70%	-50.07%	-10,653.90%	0.18	6.21	100.00%	-3,139.80%	-3,131.18%
ICU	SEASTAR MEDICAL HOLDING CORP	$10.99M	N/A	-485.60%	1,126.11%	658.40%	-3.13	0.55	100.00%	-18,392.60%	-18,209.63%
IRD	OPUS GENETICS INC	$38.21M	-180.20%	-132.30%	-225.02%	2,567.50%	1.68	3.24	100.00%	-523.40%	-523.40%
IDYA	IDEAYA BIOSCIENCES INC	$1.66B	-26.70%	-25.50%	-25.46%	-32.20%	0.06	14.97	100.00%	-3,921.10%	-3,921.10%
BIVI	BIOVIE INC	$15.50M	-141.00%	-98.30%	-94.41%	1,004.70%	0.07	16.94	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$3.26B	-32.20%	-29.50%	-31.47%	-54.10%	0.10	19.38	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$190.55M	-3.90%	-3.60%	-3.90%	-4.90%	0.07	22.63	100.00%	-12.20%	-12.16%
ABSI	ABSCI CORP	$398.56M	-49.00%	-42.10%	-55.40%	-83.20%	0.19	4.67	100.00%	-2,274.10%	-2,260.06%
IBIO	IBIO INC	$9.07M	-99.20%	-61.70%	-112.30%	-123.00%	0.56	1.76	100.00%	-5,147.50%	-5,087.20%
ALGS	ALIGOS THERAPEUTICS INC	$33.32M	-354.30%	-132.80%	-279.77%	-262.90%	-3.42	2.86	100.00%	-3,326.00%	-3,429.30%
ACRV	ACRIVON THERAPEUTICS INC	$51.42M	-46.20%	-42.30%	-44.91%	-56.40%	0.11	10.55	N/A	N/A	N/A
ACIU	AC IMMUNE SA	$164.67M	-39.90%	-23.10%	-39.04%	-101.70%	1.06	1.71	100.00%	-186.40%	-185.95%
LIPO	LIPELLA PHARMACEUTICALS INC	$6.75M	-262.50%	-197.60%	-261.34%	-1,722.50%	0.39	3.47	100.00%	-935.20%	-935.25%
CGON	CG ONCOLOGY INC	$1.70B	-14.70%	-14.40%	-12.00%	-17.70%	0.03	35.30	100.00%	-7,729.50%	-7,729.50%
QNRX	QUOIN PHARMACEUTICALS LTD	$7.33M	-114.70%	-62.60%	-77.74%	-128.30%	0.71	3.57	N/A	N/A	N/A
EPIX	ESSA PHARMA INC	$78.57M	-24.60%	-23.90%	-26.15%	-94.10%	0.03	33.12	N/A	N/A	N/A
MLYS	MINERALYS THERAPEUTICS INC	$664.81M	-68.00%	-62.40%	-92.97%	-105.10%	0.08	14.02	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$725.88M	-49.50%	-46.00%	-41.03%	-90.60%	0.09	10.77	100.00%	-2,137.50%	-2,137.48%
DSGN	DESIGN THERAPEUTICS INC	$220.24M	-19.30%	-18.70%	-20.35%	-21.70%	0.04	29.31	N/A	N/A	N/A
LQDA	LIQUIDIA CORP	$1.20B	-154.90%	-60.80%	-62.54%	-104.80%	1.98	4.43	58.00%	-931.70%	-842.44%
LGVN	LONGEVERON INC	$26.12M	-150.40%	-116.50%	-69.52%	-561.90%	0.17	7.60	78.80%	-1,029.40%	-667.77%
IRON	DISC MEDICINE INC	$1.57B	-25.20%	-23.60%	-22.90%	-54.20%	0.12	21.17	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$14.84M	-165.00%	-90.00%	-188.16%	898.10%	1.83	0.97	N/A	N/A	N/A
ARWR	ARROWHEAD PHARMACEUTICALS INC	$1.67B	-243.20%	-64.10%	-64.18%	-52.30%	18.21	6.09	100.00%	-25,588.60%	-23,617.36%
NGNE	NEUROGENE INC	$230.06M	-38.90%	-34.40%	-23.44%	-73.60%	0.08	20.84	N/A	N/A	N/A
CELU	CELULARITY INC	$36.20M	-119.50%	-25.40%	-56.82%	-27.90%	6.46	0.19	56.80%	-72.70%	-62.09%
CRBU	CARIBOU BIOSCIENCES INC	$71.99M	-50.20%	-41.50%	-52.75%	-46.40%	0.24	7.16	100.00%	-1,491.90%	-1,492.04%
HLVX	HILLEVAX INC	$92.76M	-75.30%	-58.60%	-81.68%	-107.30%	0.25	10.84	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$42.89M	N/A	-63.90%	317.16%	-457.30%	-2.12	0.48	83.70%	-66.20%	-62.66%
TELO	TELOMIR PHARMACEUTICALS INC	$75.89M	-1,166.50%	-829.70%	-1,896.34%	3,068.20%	1.06	1.94	N/A	N/A	N/A
KRRO	KORRO BIO INC	$169.85M	-48.50%	-36.40%	-39.49%	-49.80%	0.41	8.79	100.00%	-3,680.40%	-3,674.15%
CLSD	CLEARSIDE BIOMEDICAL INC	$64.96M	N/A	-107.00%	-168.96%	-64.20%	-1.65	4.44	91.00%	-2,064.40%	-2,064.42%
KROS	KEROS THERAPEUTICS INC	$576.39M	-37.90%	-35.10%	-31.79%	-462.90%	0.08	21.45	100.00%	-5,277.50%	-5,269.10%
VERV	VERVE THERAPEUTICS INC	$511.46M	-37.30%	-29.00%	-32.81%	-35.60%	0.31	12.65	100.00%	-614.60%	-613.51%
INMB	INMUNE BIO INC	$179.32M	-124.40%	-87.80%	-130.12%	736.70%	0.23	3.14	100.00%	-300,585.70%	-300,585.71%
MBX	MBX BIOSCIENCES INC	$306.50M	-67.00%	-35.10%	-24.05%	-47.90%	0.04	24.19	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$114.67M	-142.90%	-112.20%	-89.94%	-189.60%	0.17	6.50	23.10%	-1,288.30%	-1,288.25%
SLN	SILENCE THERAPEUTICS PLC	$158.52M	-64.80%	-20.30%	-23.93%	-59.40%	-0.51	11.14	72.70%	-104.70%	-102.79%
TVGN	TEVOGEN BIO HOLDINGS INC	$182.42M	N/A	-284.90%	180.78%	194.90%	-1.52	0.26	N/A	N/A	N/A
NKTX	NKARTA INC	$149.72M	-24.60%	-20.10%	-22.56%	-22.30%	0.23	14.45	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$1.63B	-45.80%	-30.80%	-40.87%	-40.50%	0.51	4.82	100.00%	-593.10%	-593.06%
URGN	UROGEN PHARMA LTD	$454.95M	-7,363.60%	-47.40%	-46.51%	-61.90%	-33.46	6.01	90.20%	-140.40%	-123.37%
DRMA	DERMATA THERAPEUTICS INC	$4.01M	-366.00%	-238.20%	N/A	-2,976.20%	1.26	N/A	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$102.69M	-43.30%	-34.40%	-43.87%	-39.10%	0.28	7.32	N/A	N/A	N/A
MTSR	METSERA INC	$1.95B	N/A	-67.50%	-56.88%	646.60%	-0.65	5.34	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$268.27M	-34.80%	-32.60%	-37.54%	-41.80%	0.12	14.96	100.00%	-5,808.80%	-5,808.82%
DMAC	DIAMEDICA THERAPEUTICS INC	$173.14M	-51.90%	-47.70%	-59.61%	-58.20%	0.14	8.28	N/A	N/A	N/A
ADCT	ADC THERAPEUTICS SA	$131.78M	N/A	-46.70%	-44.50%	-83.80%	-2.59	3.82	91.60%	-222.80%	-151.71%
CLYM	CLIMB BIO INC	$85.69M	-38.90%	-38.20%	-34.82%	-148.50%	0.03	31.41	N/A	N/A	N/A
VSTM	VERASTEM INC	$386.15M	-2,003.60%	-114.30%	-178.40%	-380.90%	-4.51	3.07	100.00%	-1,306.40%	-1,258.90%
XENE	XENON PHARMACEUTICALS INC	$2.88B	-28.50%	-27.30%	-31.27%	-32.50%	0.06	17.85	N/A	N/A	N/A
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$784.48M	-23.00%	-20.00%	-17.35%	-61.60%	0.16	7.66	96.00%	-72.80%	-67.36%
OCS	OCULIS HOLDING AG	$742.26M	-95.20%	-71.00%	-112.06%	-177.20%	0.64	2.37	100.00%	-12,503.90%	-12,434.11%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$25.91M	-329.10%	-124.80%	-214.26%	-207.40%	1.58	0.23	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$97.65M	-32.80%	-30.60%	-35.68%	-7,829.30%	0.07	14.99	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$377.77M	-42.30%	-38.00%	-21.48%	-107.20%	0.04	28.89	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$4.56M	-87.90%	-79.90%	-76.29%	-444.40%	0.12	11.58	39.60%	-7,753.20%	-7,864.33%
STRO	SUTRO BIOPHARMA INC	$75.65M	-224.10%	-52.50%	-78.07%	-95.20%	7.68	2.60	100.00%	-366.60%	-321.25%
ALLO	ALLOGENE THERAPEUTICS INC	$336.76M	-55.30%	-43.50%	-50.07%	-53.20%	0.30	8.54	100.00%	-1,170,863.60%	-1,168,027.27%
JANX	JANUX THERAPEUTICS INC	$1.84B	-9.20%	-8.80%	-6.61%	-11.10%	0.04	59.21	100.00%	-651.60%	-651.62%
AMLX	AMYLYX PHARMACEUTICALS INC	$474.91M	-127.50%	-101.10%	-182.86%	-215.00%	0.18	6.67	-42.60%	-345.40%	-345.81%
ANRO	ALTO NEUROSCIENCE INC	$63.62M	-35.60%	-31.60%	-35.85%	-662.20%	0.17	16.92	N/A	N/A	N/A
ADTX	ADITXT INC	$2.67M	-852.50%	-156.40%	-413.91%	-225.30%	48.05	0.09	-368.30%	-34,526.60%	-26,991.66%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$39.96M	N/A	-267.80%	-3,314.26%	229.90%	18.08	1.01	N/A	N/A	N/A
PEPG	PEPGEN INC	$50.02M	-61.00%	-49.90%	-67.52%	-82.90%	0.27	7.41	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$3.11B	-128.90%	-85.80%	-57.55%	-122.80%	0.29	9.61	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$3.21M	-7,384.30%	-293.60%	-240.29%	416.80%	0.41	3.43	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$398.29M	-84.80%	-45.20%	-58.55%	-90.60%	1.00	3.54	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$98.84M	-31.20%	-26.90%	-26.61%	-31.50%	0.09	12.94	N/A	N/A	N/A
MBIO	MUSTANG BIO INC	$4.03M	N/A	-159.10%	477.04%	190.00%	-3.40	0.68	N/A	N/A	N/A
RNA	AVIDITY BIOSCIENCES INC	$3.71B	-25.90%	-23.40%	-21.99%	-36.40%	0.10	15.74	100.00%	-2,957.70%	-2,957.71%
REVB	REVELATION BIOSCIENCES INC	$2.64M	-334.30%	-149.10%	-319.40%	277.60%	0.41	3.43	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$860.23M	-54.00%	-43.10%	-48.05%	-48.10%	0.37	5.77	100.00%	-896.80%	-896.77%
IGMS	IGM BIOSCIENCES INC	$78.90M	-190.70%	-61.00%	-85.85%	-72.50%	4.52	5.14	100.00%	-7,308.50%	-7,308.51%
GANX	GAIN THERAPEUTICS INC	$52.66M	-222.60%	-135.50%	-242.00%	1,091.80%	0.65	2.97	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$984.45k	-488.90%	-152.50%	-257.14%	-395.60%	2.28	1.72	N/A	N/A	N/A
VTGN	VISTAGEN THERAPEUTICS INC	$64.07M	-48.10%	-43.80%	-57.20%	-629.10%	0.14	9.35	100.00%	-6,774.20%	-6,773.01%
TRVI	TREVI THERAPEUTICS INC	$625.53M	-64.50%	-57.70%	-47.75%	-84.00%	0.11	10.41	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$335.52M	-48.30%	-43.20%	-31.64%	-60.50%	0.10	10.50	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$22.21M	-87.90%	-78.70%	-90.16%	-147.60%	0.11	3.44	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$51.01M	-502.60%	-29.20%	-26.66%	42.50%	0.13	19.96	183.00%	-7,965.80%	-8,692.06%
ALT	ALTIMMUNE INC	$390.46M	-65.30%	-58.60%	-73.77%	-95.40%	0.13	13.11	100.00%	-475,295.00%	-475,250.00%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$3.44M	-73.90%	-70.50%	-86.63%	2,890.00%	0.05	18.73	60.00%	-49,940.70%	-49,940.74%
TERN	TERNS PHARMACEUTICALS INC	$254.91M	-30.50%	-29.10%	-25.44%	-60.30%	0.05	23.14	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$286.21M	N/A	-92.80%	-89.65%	-54.10%	-2.49	4.20	85.60%	-605.10%	-474.76%
OMER	OMEROS CORP	$424.45M	N/A	-45.30%	-66.89%	-18.30%	-2.52	1.69	N/A	N/A	N/A
PRTG	PORTAGE BIOTECH INC	$9.43M	-674.40%	-415.80%	-4,189.58%	-646.10%	1.44	3.08	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$261.07M	-84.80%	-75.60%	-28.32%	-800.60%	0.10	11.48	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.69B	58.90%	53.10%	45.38%	64.10%	0.08	11.90	88.60%	1,845.90%	1,967.15%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 141.53% over the past year, overperforming other biotech stocks by 220 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 426.32% from Protalix Biotherapeutics's current stock price of $2.85.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 67.97% over the past year, overperforming other biotech stocks by 146 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.74% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 41.58% from Catalyst Pharmaceuticals's current stock price of $23.45.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.68%, which is 5 percentage points higher than the biotech industry average of 1.9%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.6%, which is 1 percentage points higher than the biotech industry average of 1.9%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.34%, which is -1 percentage points lower than the biotech industry average of 1.9%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.65% in the last day, and up 6% over the last week. Intensity Therapeutics was the among the top losers in the biotechnology industry, dropping -37.11% yesterday.

Intensity Therapeutics shares are trading lower after the company announced a $2.35 million public offering.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.35% in the past year. It has overperformed other stocks in the biotech industry by 80 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -38.52% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 3.14% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

55.47% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 108.65% over the next year.

1.53% of biotech stocks have a Zen Rating of A (Strong Buy), 5.03% of biotech stocks are rated B (Buy), 41.79% are rated C (Hold), 35.67% are rated D (Sell), and 15.97% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -157.91x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.